Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE studyAnnick Moens, Marc Ferrante, Mette Julsgaard et al.|Alimentary Pharmacology & Therapeutics|2019Cited by 137